We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 63

Timely disclosure obligation: right of action of secondary market investors
  • Langlois Lawyers LLP
  • Canada
  • August 20 2015

On November 9, 2007 amendments to Quebec’s Securities Act (the “QSA”) came into force creating a civil liability regime allowing investors on the


More than a speed bump, less than a trial: authorization of class actions for secondary market liability under Québec securities legislation
  • Gowling WLG
  • Canada
  • April 22 2015

On April 17, 2015, the Supreme Court released its unanimous decision inTheratechnologies Inc. v 121851 Canada Inc., 2015 SCC 18. The decision deals


The Supreme Court on screening out strikes suits in secondary market disclosure class actions
  • Borden Ladner Gervais LLP
  • Canada
  • April 21 2015

On April 17, 2015, the Supreme Court released its decision in TheratechnologiesInc. v. 121851 Canada Inc., 2015 SCC 18 addressing two important


Screening secondary market liability actions in Quebec: the Court of Appeal weighs in
  • McCarthy Tétrault LLP
  • Canada
  • September 13 2013

On July 17, 2013, the Quebec Court of Appeal rendered its first decision on the statutory secondary market liability regime adopted in 2007


Pharmaceutical industry scores major victory as class action is dismissed
  • Norton Rose Fulbright
  • Canada
  • May 31 2012

The Quebec Court of Appeal has sided with respondents Wyeth Consumer Healthcare Inc and Johnson & Johnson Inc in dismissing an appellant's motion for a class action.


The pharmaceutical industry scores a major victory: Court of Appeal refuses to authorize a class action
  • Norton Rose Fulbright
  • Canada
  • May 11 2012

In a judgment rendered on April 19, 2012,1 the Quebec Court of Appeal sided with the respondents Wyeth Consumer Healthcare Inc. and Johnson & Johnson Inc. and confirmed the dismissal of the appellant’s motion for authorization to institute a class action.


Karen M. Rogers
  • Langlois Lawyers LLP